Prolonged pegylated liposomal doxorubicin treatment for recurrent pelvic cancers: a feasibility study

E-ISSN： 1600-0412|94|7|776-780

ISSN： 0001-6349

Source： ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol.94, Iss.7, 2015-07, pp. : 776-780

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegylated Liposomal Doxorubicin in Recurrent Malignant Glioma: Analysis of a Case Series

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 302-307

Karger

Access to resources Recommend Favorite

Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma

Oncology Research and Treatment, Vol. 27, Iss. 6, 2004-12 ,pp. : 540-544

Karger

Access to resources Recommend Favorite

A Study of Pegylated Liposomal Doxorubicin in Platinum-Refractory Epithelial Ovarian Cancer

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 183-186

Karger

Access to resources Recommend Favorite

Phase II Study of Single-Agent Pegylated Liposomal Doxorubicin HCl (PLD) in Metastatic Breast Cancer After First-Line Treatment Failure

Oncology Research and Treatment, Vol. 27, Iss. 5, 2004-10 ,pp. : 441-446

Karger

Access to resources Recommend Favorite

Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer

Oncology Research and Treatment, Vol. 32, Iss. 1-2, 2009-01 ,pp. : 18-24

Karger

Access to resources Recommend Favorite